Skip to content

Clinical efficacy of electroacupuncture in the treatment of ineffective esophageal motility

Clinical effect of electroacupuncture with ''Hemo and points'' in the treatment of gastroesophageal reflux disease with IEM

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100048984
Enrollment
Unknown
Registered
2021-07-19
Start date
2021-08-01
Completion date
Unknown
Last updated
2022-03-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ineffective esophageal motility (IEM)

Interventions

Sponsors

Chengdu Third People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Patients who meet the diagnostic criteria of GERD and have ineffective esophageal motility; 2. Aged 18 to 70 years; 3. The patient has symptoms such as heartburn and reflux, which occur at least twice a week; 4. Not taking antacids, gastrointestinal motility drugs and other drugs that affect esophagus and gastrointestinal motility within the past 1 week; 5. Sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. Obstructive lesions of the esophagus; 2. Combined with other esophageal motility disorders such as EGJ outflow tract obstruction (achalasia, mechanical obstruction) and severe esophageal motility disorders (distal esophageal spasm, esophageal asystole, esophageal hypercontraction); 3. There is any grade of esophageal intraepithelial neoplasia or esophageal cancer, esophageal polyps, esophageal varices or ulcers, history of esophageal or gastric surgery, and hiatal hernia >=3cm; 4. There are systemic diseases, including connective tissue diseases such as systemic sclerosis, Sj?gren's syndrome, and blood system diseases such as amyloidosis; 5. Patients with severe cardiovascular and cerebrovascular, liver, kidney and hematopoietic system diseases and mental illness; 6. Pregnant and lactating patients; 7. Those who are participating in other clinical trials.

Design outcomes

Primary

MeasureTime frame
Measurement of esophageal motility;

Secondary

MeasureTime frame
Reflux event;Clinical symptoms;Quality of life;

Countries

China

Contacts

Public ContactWang Qiong

Chengdu Third People's Hospital

462602173@qq.com+86 18981948153

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026